Report overview
The global Compound Glycyrrhizin for Injection market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Compound glycyrrhizin for injection is a medication that contains a compound derived from licorice root called glycyrrhizin. It is used to treat a variety of liver diseases, including chronic hepatitis B and C, liver cirrhosis, and liver failure.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Intravenous Injection segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Compound Glycyrrhizin for Injection include Shanxi PUDE Pharmaceutical, Xi'an Lijun Pharmaceutical, Beijing Kawin Technology Share-Holding, CSPC OUYI Pharmaceutical, North China Pharmaceutical, Cisen Pharmaceutical, Harbin Medisan Pharmaceutical, Anhui Hongye Pharmaceutical, Reyoung Pharmaceutical, Chengdu Easton Bio Pharmaceuticals, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Compound Glycyrrhizin for Injection manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Compound Glycyrrhizin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compound Glycyrrhizin for Injection. This report contains market size and forecasts of Compound Glycyrrhizin for Injection in global, including the following market information:
Global Compound Glycyrrhizin for Injection market revenue, 2020-2025, 2026-2032, ($ millions)
Global Compound Glycyrrhizin for Injection market sales, 2020-2025, 2026-2032, (K Units)
Global top five Compound Glycyrrhizin for Injection companies in 2024 (%)
Total Market by Segment:
Global Compound Glycyrrhizin for Injection market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Compound Glycyrrhizin for Injection market segment percentages, by Type, 2024 (%)
Intravenous Injection
Intravenous Drip
Global Compound Glycyrrhizin for Injection market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Compound Glycyrrhizin for Injection market segment percentages, by Application, 2024 (%)
Chronic Liver Disease
Eczema
Dermatitis
Other
Global Compound Glycyrrhizin for Injection market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Compound Glycyrrhizin for Injection market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Compound Glycyrrhizin for Injection revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Compound Glycyrrhizin for Injection revenues share in global market, 2024 (%)
Key companies Compound Glycyrrhizin for Injection sales in global market, 2020-2025 (estimated), (K Units)
Key companies Compound Glycyrrhizin for Injection sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanxi PUDE Pharmaceutical
Xi'an Lijun Pharmaceutical
Beijing Kawin Technology Share-Holding
CSPC OUYI Pharmaceutical
North China Pharmaceutical
Cisen Pharmaceutical
Harbin Medisan Pharmaceutical
Anhui Hongye Pharmaceutical
Reyoung Pharmaceutical
Chengdu Easton Bio Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Compound Glycyrrhizin for Injection, market overview.
Chapter 2: Global Compound Glycyrrhizin for Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Compound Glycyrrhizin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Compound Glycyrrhizin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Compound Glycyrrhizin for Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
